THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Dr. Ezra Cohen, photo courtesy UCSD Hematologic malignancies are cancers that affect the blood, bone marrow and lymph nodes and include different forms of leukemia and lymphoma. Current treatments can be effective, but in those patients that do not respond, there are few treatment options. Today, … Continue reading Stem Cell Agency Board Invests in Therapy Targeting Deadly Blood Cancers
CIRM Fights Cancer
A new approach to a deadly childhood cancer
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Cancers of the blood, bone marrow and lymph nodes (also called hematologic malignancies) are the most common form of cancer in children and young adults. Current treatments can be effective but can also pose life-threatening health risks to the child. Now researchers at Stanford have developed … Continue reading A new approach to a deadly childhood cancer
CIRM funds clinical trials targeting heart disease, stroke and childhood brain tumors
Gary Steinberg (Jonathan Sprague) Heart disease and stroke are two of the leading causes of death and disability and for people who have experienced either their treatment options are very limited. Current therapies focus on dealing with the immediate impact of the attack, but there is nothing to deal with the longer-term impact. The CIRM … Continue reading CIRM funds clinical trials targeting heart disease, stroke and childhood brain tumors
Saying thanks and farewell to a friend
Tom Howing In this job you get to meet a lot of remarkable people, none more so than the patients who volunteer to take part in what are giant experiments. They are courageous pioneers, willing to be among the first people to ever try a new therapy, knowing that it may not help them and, … Continue reading Saying thanks and farewell to a friend
How early CIRM support helped an anti-cancer therapy overcome obstacles and help patients
Dr. Catriona Jamieson, UC San Diego When you read about a new drug or therapy being approved to help patients it always seems so simple. Researchers come up with a brilliant idea, test it to make sure it is safe and works, and then get approval from the US Food and Drug Administration (FDA) to … Continue reading How early CIRM support helped an anti-cancer therapy overcome obstacles and help patients
Three teams empower patients’ immune systems to oust cancer
Immuno-oncology is all the rage now in biotech publications, with due cause. It is producing some pretty impressive results in patients who failed other therapies. Most of what gets written about involves strengthening or unlocking the action of one immune cell, the T cell. But our immune systems are armed with many types of ammunition; … Continue reading Three teams empower patients’ immune systems to oust cancer
One man’s story points to hope against a deadly skin cancer
At our May Board meeting a gentleman presented his story, which exemplifies being a patient and patient advocate. His name is Norm Beegun. And this is his story. Norm lives in Los Angeles. In 2002 he went to see his regular doctor, an old high school friend, who suggested that since it had been almost … Continue reading One man’s story points to hope against a deadly skin cancer
CIRM Fights Cancer: Two teams develop therapies to stop and eliminate cancer stem cells
Six out of the ten best selling drugs are proteins called monoclonal antibodies. But the prospect for monoclonal antibodies was not always so bright. It took a decade after their discovery in 1975 before they found any clinical use, even then it was very limited use for organ transplant rejection. It was a full twenty … Continue reading CIRM Fights Cancer: Two teams develop therapies to stop and eliminate cancer stem cells
Pioneering patients heroes of early clinical trials
When Frank Gonzales was diagnosed with colorectal cancer in November 2010 it was the start of a long fight against the disease. Chemotherapy helped keep the cancer in check, but it wasn’t a cure. So when Frank heard about a new experimental treatment, that seeks out and destroys cancer stem cells, he was intrigued. Frank … Continue reading Pioneering patients heroes of early clinical trials
CIRM fights cancer: $56 million for 5 clinical trials to vanquish tumors for good
[This is the first of three stories on CIRM’s Cancer Fight that we will post this week. Tomorrow’s will discuss two projects that attack cancer stem cells directly and Thursday's will describe three projects that help our immune system wipe out the traitorous cells.] It’s back—two words we would like to remove from the cancer … Continue reading CIRM fights cancer: $56 million for 5 clinical trials to vanquish tumors for good
The Stem Cellar 